National Institutes of Health: Memory Disorders trials

The registry lists 10 Memory Disorders studies with National Institutes of Health as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 2Phase 2 3Phase 3 2No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) GenotypeTerminatedNCT00548327Phase 2Results posted
• Brain Areas Involved in Sound and Spoken Word MemoryTerminatedNCT01375595
• Nicotine Treatment of Mild Cognitive Impairment (MCI)Status unknownNCT00091468Phase 1
• Phytoestrogens and Memory Decline in MenopauseCompletedNCT00051402Phase 2
• Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon AlphaStatus unknownNCT00031018Phase 2
• Evaluation of Age- and Alzheimer's Disease-Related Memory DisorderCompletedNCT00029120
• Preventing Cognitive Decline With Alternative TherapiesCompletedNCT00010920Phase 3
• The Evaluation and Follow-up of Individuals With Memory DisorderCompletedNCT00001480
• AIT-082 Phase 1B StudyCompletedNCT00000180Phase 1
• Alzheimer's Disease Prevention TrialCompletedNCT00000176Phase 3